Cargando…
The Interplay between Chronic Pain, Opioids, and the Immune System
Chronic pain represents one of the most serious worldwide medical problems, in terms of both social and economic costs, often causing severe and intractable physical and psychological suffering. The lack of biological markers for pain, which could assist in forming clearer diagnoses and prognoses, m...
Autores principales: | Malafoglia, Valentina, Ilari, Sara, Vitiello, Laura, Tenti, Michael, Balzani, Eleonora, Muscoli, Carolina, Raffaeli, William, Bonci, Antonello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647319/ https://www.ncbi.nlm.nih.gov/pubmed/34269117 http://dx.doi.org/10.1177/10738584211030493 |
Ejemplares similares
-
Chronic Pain: What Does It Mean? A Review on the Use of the Term Chronic Pain in Clinical Practice
por: Raffaeli, William, et al.
Publicado: (2021) -
A Review of the Clinical and Therapeutic Implications of Neuropathic Pain
por: Balzani, Eleonora, et al.
Publicado: (2021) -
Identification of MOR-Positive B Cell as Possible Innovative Biomarker (Mu Lympho-Marker) for Chronic Pain Diagnosis in Patients with Fibromyalgia and Osteoarthritis Diseases †
por: Raffaeli, William, et al.
Publicado: (2020) -
Lymphocyte opioid receptors as innovative biomarkers of osteoarthritic pain, for the assessment and risk management of opioid tailored therapy, before hip surgery, to prevent chronic pain and opioid tolerance/addiction development: OpMarkArt (Opioids-Markers-Arthroprosthesis) study protocol for a randomized controlled trial
por: Malafoglia, Valentina, et al.
Publicado: (2017) -
An Observational Study on Chronic Pain Biomarkers in Fibromyalgia and Osteoarthritis Patients: Which Role for Mu Opioid Receptor’s Expression on NK Cells?
por: Malafoglia, Valentina, et al.
Publicado: (2023)